1. Home
  2. FET vs ANNX Comparison

FET vs ANNX Comparison

Compare FET & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$80.95

Market Cap

850.2M

Sector

Industrials

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.18

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FET
ANNX
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
850.2M
873.3M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
FET
ANNX
Price
$80.95
$4.18
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$16.50
AVG Volume (30 Days)
154.3K
2.7M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
92.64
N/A
EPS
0.39
N/A
Revenue
$791,474,000.00
N/A
Revenue This Year
$7.35
N/A
Revenue Next Year
$6.95
$16,320.74
P/E Ratio
$207.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.07
$2.54
52 Week High
$87.42
$7.18

Technical Indicators

Market Signals
Indicator
FET
ANNX
Relative Strength Index (RSI) 57.71 39.34
Support Level $75.68 $3.79
Resistance Level $85.79 $5.63
Average True Range (ATR) 3.26 0.21
MACD -0.64 -0.00
Stochastic Oscillator 59.58 37.35

Price Performance

Historical Comparison
FET
ANNX

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: